Jump to content

All Activity

This stream auto-updates     

  1. Yesterday
  2. THE FAKEST and most biased Newspaper on the Planet? New York Times Executive Editor Outlines Plans to Shift Trump Coverage from Russia to Race xx The New York Times plans to shift its coverage of President Trump from whether he colluded with Russia to race, the paper’s executive editor Dean Baquet said during a recent staff meeting, according to a transcript of the meeting posted by Slate.com. “And I mean race in terms of not only African Americans and their relationship with Donald Trump, but Latinos and immigration,” he said, according to the transcript of the meeting, which reportedly took place on Monday.
  3. WTF ?? Jeffrey Epstein Reportedly Shipped a Cement Truck to His Island Last Year, Experts Fear Evidence ‘Cover Up’
  4. Stefan Molyneux sums it up EVERYTHING WRONG WITH THE EPSTEIN STORY!
  5. Easy Rider - Intro - Born to be wild! Peter Fonda and the Captain America Bike "Tell Me We Haven't Blown It": Peter Fonda Reflects on 'Easy Rider' and Its Unanswered Question == Leftist Actor Peter Fonda Dead at 79
  6. Last week
  7. https://en.wikipedia.org/wiki/Deep_state_in_the_United_States
  8. Hi Hector, please expand on " The deep state was behind Epstein's murder". I do not understand the term "the deep state". Sorry about my ignorance. Thanks.
  9. The deep state was behind Epstein's murder. People are waking up but there's nothing that can be done.
  10. Review of Dem candidates Michael Knowles | The Ben Shapiro Show Sunday Special Ep. 62
  11. More dirt. The black-run prison was a shambles... Can they really get "accountability"? Epstein guards suspected of falsifying jail logs
  12. I think the Hong Kong outlook is markedly different from what it was only a year ago... I think the fear is justified.
  13. Pro Free Speech Infowars Founder Alex Jones, Anti-Free Speech Google Tyrant Sundar Pichai Google Whistleblower Zach Vorhies: ‘Justice is Coming’ to Big Tech [VIDEO]
  14. CONFUSING? BIBI BLOCKS OMAR, TLAIB FROM ENTERING ISRAEL... JERUSALEM (AP) — With a push from President Donald Trump, Israel on Thursday barred two Muslim-American congresswomen from entering the country for a visit, an extraordinary step bringing the longtime U.S. ally into Trump’s domestic fight against political rivals at home. The U.S. president is essentially relying on Israel to retaliate against two freshman lawmakers, Reps. Rashida Tlaib of Michigan and Ilhan Omar of Minnesota, who are both outspoken critics of Israel’s treatment of Palestinians. They are also part of the “squad” of liberal newcomers -- all women of color -- whom Trump has labeled the face of the Democratic Party as he runs for reelection. AIPAC condemns... The American Israel Public Affairs Committee (AIPAC) on Thursday broke with Israel's decision to bar Democratic Reps. Ilhan Omar (Minn.) and Rashida Tlaib (Mich.) from visiting the country, saying "every member of Congress should be able to visit." "We disagree with Reps. Omar and Tlaib’s support for the anti-Israel and anti-peace BDS movement, along with Rep. Tlaib’s calls for a one-state solution. We also believe every member of Congress should be able to visit and experience our democratic ally Israel firsthand," AIPAC tweeted Thursday. . . . The statement follows Israel's announcement that the House Democrats will be prevented from entering the country as part of a planned trip over their support for the boycott, divestment and sanctions (BDS) movement against Israel. Israel's announcement came shortly after President Trump urged the country to bar the progressive lawmakers from entering. Israeli Prime Minister Benjamin Netanyahu defended his country’s decision, citing an Israeli law that prohibits entry into the country for individuals who support a boycott of Israel. “As a vibrant and free democracy, Israel is open to any critic and criticism, with one exception: Israel’s law prohibits the entry of people who call and operate to boycott Israel, as is the case with other democracies that prevent the entry of people whose perception harms the country," he said in a statement posted to his official Facebook page. Omar and Tlaib have been vocal advocates of Palestinian rights and BDS. They were among 17 Democrats to vote against a bill to oppose BDS last month.
  15. Americans Say Murder More Likely Than Suicide in Epstein Case Americans aren’t buying that disgraced financier and convicted sex criminal Jeffrey Epstein killed himself in jail last weekend. Read more
  16. Was able to completely sell down my position without loss after I doubled up at 576 on August 1. Playing with the long term trend here and not expecting a fast recovery to £8 although I admit it may well be possible if silver stays bid.
  17. Canaccord Preferred vs. CF.t shares CF.prA vs- CF.t ... update / Last: $5.08 / $13.96 = R-36.4% ==
  18. NEWS Recent Bulletins News ReleasesIn The NewsOther Date ET Symbol Price Type Headline 2019-08-14 18:15 C:CF 5.08 Street Wire SEC fines Canaccord $250,000 (U.S.) for OTC violations 2019-08-14 10:42 C:CF 5.26 News Release Canaccord Genuity to buy back 7.27M shares for $39.99M 2019-08-12 17:03 C:CF 5.12 News Release Canaccord arranges NCIB for 5.42 million shares 2019-08-12 08:53 C:CF 5.12 News Release Canaccord Genuity to take up 7.27M shares in issuer bid === WAS OVERSUBSCRIBED Canaccord Genuity Group Inc. will take up and purchase for cancellation 7,272,727 of its common shares at a purchase price of $5.50 per common share under the company's substantial issuer bid for aggregate consideration of $39,999,998.50. Common shares purchased under the offer represent approximately 6.28 per cent of the issued and outstanding common shares on a non-diluted basis as at July 3, 2019, the time the offer was announced. After giving effect to the offer, 108,474,831 common shares will be issued and outstanding. A total of approximately 18,918,198 common shares were properly tendered to the offer and not withdrawn. As the offer was oversubscribed, shareholders who made auction tenders at a price of $5.50 and purchase price tenders will have approximately 59 per cent of their successfully tendered common shares purchased by the company ===
  19. The FRUIT of FEAR? HK10 may be at/near a LT Buying window HK10 / Hang Lung Group... update : HK101 : hk10-101-2823 : 10d / Last: $19.16
  20. Ho Hum... Can you name everyone in the photo yet... thats 4 of them. 2 to go and you'll have a full house.
  21. NOT popular in their districts Outside funding comes from scumbags like Soros, Cenk Yogurt & TYT Far left Democrats Are Failing In Their Districts, Abysmal Polling And Almost No Top Donors
  22. Missing Punchline! WHY the Low Earnings? > Q2.financials When the GCM stock price rises, the O/S warrants generate Losses "Adjusted net income (1) for the second quarter of 2019 was $14.0 million, or $0.29 per share, up from $8.2 million, or $0.29 per share, in the second quarter last year. For the first half of 2019, adjusted net income amounted to $27.0 million, or $0.56 per share, compared with $18.1 million, or $0.72 per share, in the first half last year." Adj. Net for Q2 was $14.0 Million, Yet... Reported Earnings for Q2 were just: $768k. Why?? Because of the LOSS on Financial Instruments. This rose by over $6.5M in Q2, vs Q1 & very heavy 92% income taxes- See Below ======================= Q1-2019: Q2-2019: 6mo-'19: Income from operations…….. : 25,325 : 24,885 : 50,210 : Other income (expense) Finance income……………….….. : 271 : 367 : 638 : Finance costs………………….….. : (2,707) : (3,843) : (6,550) : Foreign exchange loss……….. : (132) : (427) : (559) : Loss, equity in associate……. : (82) : (128) : (210) : Loss on financial instruments (4,591) : (11,057): (15,648): =======================: (7,241) : (15,088): (22,329) : Income before income tax. : 18,084 : 9,797 : 27,881 : Income tax (expense)……..… : (10,526): (9,710): (20,236): Deferred tax…………………..….. : 345 : 681 : 1,026 : ===================== : (10,181) : (9,029): (19,210): Net income (loss) ……………. : $ 7,903 : $ 768 : $ 8,671 : 15. LOSS ON FINANCIAL INSTRUMENTS ======================== Q1-2019: Q2-2019: 6mo-'19: MTM loss on Gold Notes (7a): $ (1,896): $(4,380): $(6,274): MTM loss on Conv. Debs (7b): $ (0): (1,659): (1,659): Fair value adj. on SSP Wts. : $ (127): (2): (129): (Loss) on gold in Gold Trust : $ 123 : (53): 70: MTM, gold hedging contracts: $ (124): (151): (275): MTM loss on 2024 Wt liability: $(2,569): (4,812): (7,381): =======================. $ (4,591): (11,057): (15,648): Net income (loss) ………….……. : $ 7,903 : $ 768 : $ 8,671 : As at June 30, 2019, the Company had a total of 12,074,808 listed warrants (GCM.WT.B) (the “2024 Warrants”) issued and outstanding. The 2024 Warrants were issued on April 30, 2018 and commenced trading on the TSX on September 6, 2018. The 2024 Warrants have an exercise price of CA$2.21 per share and entitle holders to purchase one common share of the Company for each 2024 Warrant at any time prior to their expiry on April 30, 2024. The 2024 Warrants represent a financial liability as the exercise price is denominated in Canadian dollars, different from the Company’s US dollar functional currency. As such, they were recognized at fair value at inception and subsequently remeasured with the change in fair value being recognized in the statement of operations. The fair value of the 2024 Warrants as at June 30, 2019 was determined based on their last traded price, a level 1 fair value input, of CA$2.28 ($1.74) per 2024 Warrant for the period. ===== Bizarrely, when the price of the warrants goes up, Earnings take a hit ! In the first half of 2019, this almost wiped out earnings. Q3 could be worse ======================== Q1-2019: Q2-2019: 6mo’19: Aug.14th MTM loss on 2024 Wt liability : $(2,569): (4,812): (7,381): (11M ?) : Qtr End Mkt.Value WtB C$1.40: C$1.80 : C$2.28 : C$2.28 : C$3.58 : Change in WtB price …………..…. : C$0.40 : C$0.48 : C$0.88 : C$1.30 : —————————-x 12.07 Mn : C$4,828: $5,794 : 10,622 : 15,691 : —————————- / USDCAD : C$1.350: $1.310 : $1.310 : $ 1.330 : —————————-x 12.07 Mn. : $ 3,576 : $4,423 : $8,108 : 11,798 : Qtr End value, WtB : US$1.026 : $ 1.360 : $1.740 : $1.740 : $2.720 : Change in WtB price ……………... : $ 0.334 : $0.380 : $0.714 : $0.980 : —————————-x 12.07 Mn : $4,031 : $4,587 : $8,618 : 11,829 : But GCM has to pay Income Tax on the earnings BEFORE this odd expense. Is it a real expense? I don't think it is. When they sell Wts at an exercise price, and later the price rises, it is a mere opportunity loss. A company does not take an earnings hit, when it sells stock at a low price, and later the price rises.
  23. Gran Colombia earns $768,000 (U.S.) in Q2 // The Punchline is Missing ! > Q2.financials GRAN COLOMBIA GOLD REPORTS SECOND QUARTER AND FIRST HALF 2019 RESULTS; RAISES 2019 PRODUCTION GUIDANCE AND ON TRACK TO MEET 2019 COST GUIDANCE Gran Colombia Gold Corp. has released its unaudited interim condensed consolidated financial statements and accompanying management's discussion and analysis for the three and six months ended June 30, 2019. All financial figures contained herein are expressed in U.S. dollars ("USD") unless otherwise noted. Lombardo Paredes, Chief Executive Officer of Gran Colombia, commenting on the Company's latest results, said, "We are pleased with our second quarter 2019 operating and financial results. We have now raised our production guidance for the year and we are on track to meet this year's cost guidance. For the first half of this year, our revenue was up 16%, our adjusted EBITDA was up 27%, our operating cash flow up in gold prices, well above the average for the first half of this year, our second half earnings, cash flows and cash balance are poised to benefit from our leverage to gold prices. We've continued to improve our liquidity in the second quarter, bolstering our mid-year cash position to $51.3 million, including the net proceeds of the Convertible Debentures financing completed in April. The recently announced high-grade results from our drilling program at Segovia in the first half of 2019, and the work we are doing to identify and prioritize step out and brownfield drilling targets, increase our confidence in the potential to add mineral reserves and extend mine life at our flagship operation." Second Quarter and First Half 2019 Highlights The strength of the Company's operating performance at its high-grade Segovia Operations in the first half of 2019 has allowed it to raise its annual gold production guidance for 2019 to a range of between 225,000 and 240,000 ounces. Total gold production of 57,882 ounces in the second quarter of 2019, up 9% over the second quarter last year brought the total for the first half of 2019 to 118,483 ounces, up 12% over the first half last year. With another 18,166 ounces produced in July, the Company's trailing 12-months' gold production at the end of July 2019 now stands at 229,776 ounces, up 5% over 2018's annual production. Revenue amounted to $77.6 million in the second quarter of 2019, up 13% over the second quarter last year, bringing the total revenue for the first half of 2019 to $155.1 million, up 16% over the first half last year. 2019's revenue increase has been largely driven by the production growth. Despite a 1% year-over-year decline in spot gold prices to an average of $1,307 per ounce in the first half of 2019, the Company reported a $6 per ounce improvement in realized gold prices to an average of $1,296 per ounce in the first half this year. This was the result of lower charges in a new refining contract that the Company entered into in January 2019 with an international refinery, saving approximately $20 per ounce sold compared with its previous arrangement. With the London P.M. Fix gold price ranging from a low of $1,390 per ounce to a high of $1,506 per ounce thus far in the third quarter, the Company expects to see a significant increase in revenue and operating cash flow in the second half of 2019 compared with the first half of 2019 if spot gold prices remain at the current level. Total cash costs (1) per ounce, continuing to benefit from solid operating performance at its Segovia Operations, was $655 per ounce in the second quarter of 2019, down from $696 per ounce in the second quarter last year, bringing the average for the first half of 2019 to $638 per ounce, down from $683 per ounce in the first half last year. For 2019, the Company now expects that its total cash costs for the full year will remain below 2018's annual average of $680 per ounce. All-in sustaining costs ("AISC") (1) and All-in costs (1) in the second quarter of 2019 were $878 per ounce and $903 per ounce, respectively, both down from $930 per ounce and $937 per ounce, respectively, in the second quarter last year. For the first half of 2019, AISC and All-in costs per ounce were $855 and $873 per ounce, respectively, down from $925 and $929, respectively, in the first half last year. For 2019, the Company expects that its AISC and All-in costs for the full year will remain below $925 per ounce and $950 per ounce, respectively. The Company reported adjusted EBITDA (1) of $33.2 million for the second quarter of 2019, up 25% over the second quarter last year, bringing the total for the first half of 2019 to $68.5 million, up 27% over the first half last year. The trailing 12-months' adjusted EBITDA at the end of June 2019 now stands at $116.9 million, up 14% over 2018, driven by production growth and the reduction in total cash costs per ounce sold. Net cash provided by operating activities in the second quarter of 2019 of $18.2 million brought the total for the first half of 2019 to $38.0 million, up 7% over the first half last year. The Company's Free Cash Flow (1) in the second quarter of 2019 of $7.8 million brought the total for the first half of 2019 to $19.0 million, up 3% over the first half last year. . . . Adjusted net income (1) for the second quarter of 2019 was $14.0 million, or $0.29 per share, up from $8.2 million, or $0.29 per share, in the second quarter last year. For the first half of 2019, adjusted net income amounted to $27.0 million, or $0.56 per share, compared with $18.1 million, or $0.72 per share, in the first half last year. Improved earnings in the second quarter and first half of 2019 compared with the corresponding periods last year continued to reflect the significant contribution of Segovia's operating performance in 2019 on revenues, total cash costs per ounce, adjusted EBITDA and income from operations.
  24. Experion Holdings Ltd Update Recent Bulletins News ReleasesIn The NewsOther Date ET Symbol Price Type Headline 2019-08-06 09:51 C:EXP 0.215 News Release Experion has claim for 10.27 M shares dismissed 2019-07-25 11:08 C:EXP 0.24 News Release Experion's chairman McWatters dies 2019-07-24 13:19 C:EXP 0.24 News Release Experion files Q2 financials, talks recent work 2019-07-24 12:23 C:EXP 0.24 SEDAR Interim Financial Statements SEDAR Interim Financial Statements 2019-07-24 12:23 C:EXP 0.24 SEDAR MD & A SEDAR MD & A VANCOUVER, British Columbia, July 24, 2019 (FSCwire) Experion Holdings Ltd. (“Experion” ... Financials Experion has now filed its Q2 2019 consolidated interim financial statements, and management discussion and analysis for the six months ended May 31, 2019 on SEDAR. Business Update – Domestic and International Market Development Domestic Market: In January 2019, the Company begun to sell clones to newly licensed Standard Cultivators looking for quality genetics to launch their cultivation process. The sales expand Experion’s product line with clones exhibiting the desired specifications and attributes for both the medical and Adult-use market. Under the Cannabis Act, a cultivation license can sell product to other licensed facilities fostering new business to business relationships and the ability to create quick strategic partnerships as the market becomes established. All starting materials sold as clones to other cultivators have a flower buy back program with Experion. As well, Experion can also sell clones for medical purposes to qualified individuals as a licensed medical supplier. International Market: In June 2019, Experion signed a non-binding letter of intent (“LOI”) with a Polish import and distribution company to export medical flower products to Poland. Under the executed LOI, Experion will export medical flower products to Poland for scientific purposes enabling the Polish company to test and develop Experion’s flower products. After the successful completion of this testing, Experion will export its flower products to Poland for consumer medical use. Experion is currently working towards European Union Good Manufacturing Practice (“GMP”) certification of its Mission facility in British Columbia, which will allow the export of cannabis to the EU for medical consumption. Experion is actively seeking export opportunities in Europe and plans to continue to build its international distribution chain. Corporate Update During the current period, Experion continued to strengthen is executive team and appointed Kamini Hitkari to the position of Chief Financial Officer. The Company also hired Judy-Ann Pottinger to provide comprehensive investor relations and corporate communications services. On June 10, 2019, Experion changed its name from Viridium Pacific Group Ltd. to Experion Holdings Ltd. and changed its trading symbol from “VIR” to “EXP” on the TSXV. A focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders.
  25. I am happy I dumped this shortly after the foray into Marijuana labs VIR > EXP / EXPERION Holdings ... all-data : vs-WEED : 5-yr : 2-yr : 12mo :: : EXP-vs-WEED : “Experion Holdings Ltd.” (TSX-V: EXP). June 10, 2019 (Source) – Viridium Pacific Group Ltd. (the ”Company”) (TSX-V: VIR ) is pleased to announce that the Company has changed its name from “Viridium Pacific Group Ltd.” to “Experion Holdings Ltd.” (TSX-V: EXP).The Company’s shareholders approved the name change at a special meeting of shareholders held on May 31, 2019. Effective on market opening on June 10, 2019, the common shares of the Company will commence trading on the TSX Venture Exchange under the Company’s new name, Experion Holdings Ltd., and under the trading symbol ”EXP”. With the new change in name, there is no consolidation of capital and the CUSIP Number will be 30219B109. Mr. Jay Garnett, Chief Executive Officer, commented, “We are excited to have both our Licence and corporate entity under Experion. Having a focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders. In addition, it will allow us to better communicate our value proposition as we work to unlock value and communicate our accomplishments to the market and stakeholders.” No action is required to be taken by current shareholders in connection with the change in name and no change has been made to Experion Holdings Ltd. share capital. About Experion Holdings Ltd. Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB. Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Medical, Adult-use, and Wellness and Therapeutic products.
  26. After the yield curve inverts — here’s how the stock market tends to perform since 1978 The inversion of the main measure of the yield curve, or a negative spread between short-term and long-term yields, has preceded the last seven recessions. However, that doesn’t mean that recessionary jitters will spark a lasting selloff in equity markets. On average, the S&P 500 has returned 2.5% after a yield-curve inversion in the three months after the episode, while it has gained 4.87% in the following six months, 13.48% a year after, 14.73% in the following two years, and 16.41% three years out, according to Dow Jones Market Data (see table below): Date of first 2/10-year inversion 3 months later 6 months later 1 year 2 years 3 years 8/17/1978 -10.14% -6.10% 3.06% 19.64% 24.88% 8/20/1980 13.44% 2.27% 5.59% -8.69% 32.49% 12/9/1988 6.10% 17.93% 25.87% 18.31% 36.54% 5/26/1998 -0.90% 8.49% 19.26% 25.96% 16.81% 12/30/2005 4.16% 1.76% 13.62% 18.44% -28.65% Average 2.53% 4.87% 13.48% 14.73% 16.41% Read: These stocks are falling the most as Treasury yield curve inverts On top of all that, a yield-curve inversion, doesn’t instantly result in an economic recession. From 1956, past recessions have started on average around 15 months after an inversion of the 2-year/10-year spread occurred, according to Bank of America Merrill Lynch. See full story. Dow tumbles 800 points in biggest one day fall of year on global economic growth slowdown U.S. stocks fell sharply Wednesday, following a series of worrying data on global economic growth, and after the yield on the 10-year U.S. Treasury note fell below that of the 2-year note, marking an inversion of the main measure of the yield curve, flashing a recession warning signal. See full story.
  1. Load more activity
×